Crossmark Global Holdings’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-1,217
Closed -$261K – 1318
2023
Q3
$261K Buy
1,217
+11
+0.9% +$2.2K 0.01% 1082
2023
Q2
$232K Sell
1,206
-32
-3% -$6.36K 0.01% 1189
2023
Q1
$250K Buy
+1,238
New +$199K 0.01% 1127
2022
Q3
– Sell
-1,351
Closed -$239K – 1288
2022
Q2
$239K Buy
+1,351
New +$195K 0.01% 1147
2021
Q4
– Sell
-2,891
Closed -$491K – 1490
2021
Q3
$491K Buy
+2,891
New +$450K 0.01% 933
2018
Q4
– Sell
-3,405
Closed -$263K – 1579
2018
Q3
$263K Buy
3,405
+40
+1% +$2.95K 0.01% 1403
2018
Q2
$223K Buy
+3,365
New +$193K 0.01% 1488
2018
Q1
– Sell
-5,090
Closed -$272K – 1637
2017
Q4
$272K Buy
5,090
+55
+1% +$3.21K 0.01% 1426
2017
Q3
$274K Buy
+5,035
New +$258K 0.01% 1375
2016
Q3
$274K Buy
+5,035
New +$239K 0.01% 1375

Other funds holding SGEN

Crossmark Global Holdings's SGEN Position: Q4 2023 in Review

Crossmark Global Holdings sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 1,217 shares — an estimated $261K sold.

Crossmark Global Holdings first reported a position in SGEN in Q3 2016 and held it in 10 quarters. The position peaked at $491K in Q3 2021. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Crossmark Global Holdings reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Crossmark Global Holdings sold 1,217 Seagen Inc. Common Stock shares in Q4 2023, an estimated $261K.
  • Crossmark Global Holdings first reported a position in Seagen Inc. Common Stock in Q3 2016 and held it in 10 quarters.
  • Crossmark Global Holdings's Seagen Inc. Common Stock position peaked at $491K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Crossmark Global Holdings's 13F filing for Q4 2023, filed 13 Feb 2024.